Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -102,329 | -65,175 | -35,410 | -14,873 | -52,371 |
| Depreciation Amortization | -4,837 | -4,465 | -3,133 | -1,719 | -2,937 |
| Accounts payable and accrued liabilities | 4,269 | 963 | 2,823 | 1,700 | -261 |
| Other Working Capital | 11,653 | 3,432 | -302 | -4,067 | 3,866 |
| Other Operating Activity | 5,029 | 6,245 | 1,618 | 1,100 | 8,639 |
| Operating Cash Flow | $-86,215 | $-59,000 | $-34,404 | $-17,859 | $-43,064 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 48,043 | 18,380 | 28,512 | -9,192 | -171,653 |
| PPE Investments | -16 | -16 | -16 | -11 | -18 |
| Investing Cash Flow | $48,027 | $18,364 | $28,496 | $-9,203 | $-171,671 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 30,000 |
| Debt Repayment | -739 | -739 | -739 | -739 | N/A |
| Common Stock Issued | 7,938 | 7,938 | 7,938 | 7,938 | 122,229 |
| Common Stock Repurchased | -41 | -32 | -32 | -32 | N/A |
| Other Financing Activity | -230 | -230 | -188 | -60 | -476 |
| Financing Cash Flow | $6,928 | $6,937 | $6,979 | $7,107 | $151,753 |
| Beginning Cash Position | 67,119 | 67,119 | 67,119 | 67,119 | 130,101 |
| End Cash Position | 35,859 | 33,420 | 68,190 | 47,164 | 67,119 |
| Net Cash Flow | $-31,260 | $-33,699 | $1,071 | $-19,955 | $-62,982 |
| Free Cash Flow | |||||
| Operating Cash Flow | -86,215 | -59,000 | -34,404 | -17,859 | -43,064 |
| Capital Expenditure | -16 | -16 | -16 | -11 | -21 |
| Free Cash Flow | -86,231 | -59,016 | -34,420 | -17,870 | -43,085 |